Sellas Life Sciences Shares Rise Up to 12% After Hours
Sellas shares rose up to 12% in extended trading Monday as traders weighed Eli Lilly’s Calytrix deal against the company’s valuation. Filings showed Susquehanna and Prudential added 1.3 million shares in the third quarter.
Shares of Sellas Life Sciences (SLS) jumped up to 12% in extended trading on Monday as traders weighed Lilly’s Calytrix deal against Sellas’s valuation, while filings showed that Susquehanna and Prudential added 1.3 million shares in Q3.SLS stock slid 5% on Monday to $7.47, logging its third straig…